"Strict" blood pressure control and progression of renal disease in hypertensive nephrosclerosis.

[1]  T V Perneger,et al.  Projections of hypertension-related renal disease in middle-aged residents of the United States. , 1993, JAMA.

[2]  A. Relman.  Race and end-stage renal disease. , 1982, The New England journal of medicine.

[3]  P. Eggers,et al.  The Medicare experience with end-stage renal disease: Trends in incidence, prevalence, and survival , 1984, Health care financing review.

[4]  S. Rostand,et al.  Racial differences in the incidence of treatment for end-stage renal disease. , 1982, The New England journal of medicine.

[5]  J. Ware,et al.  Random-effects models for longitudinal data. , 1982, Biometrics.

[6]  G. Beck,et al.  The Effects of Dietary Protein Restriction and Blood-Pressure Control on the Progression of Chronic Renal Disease , 1994 .

[7]  C. Dollery,et al.  Prognosis of treated hypertension. Changes in life expectancy and causes of death between 1952 and 1967. , 1970, The Quarterly journal of medicine.

[8]  S. Rosansky,et al.  The association of blood pressure levels and change in renal function in hypertensive and nonhypertensive subjects. , 1990, Archives of internal medicine.

[9]  A. Hull,et al.  Measurement of glomerular filtration rate utilizing a single subcutaneous injection of 125I-iothalamate. , 1973, Kidney international.

[10]  J. Dunphy.  Surgery's relevance to an understanding of basic biology. Tissue repair and cellular regeneration. , 1967, JAMA.

[11]  W. Pettinger,et al.  Long‐Term Improvement in Renal Function After Short‐Term Strict Blood Pressure Control in Hypertensive Nephrosclerosis , 1989, Hypertension.

[12]  W. Pettinger,et al.  Renal function during long-term treatment of hypertension with minoxidil: comparison of benign and malignant hypertension. , 1980, Annals of internal medicine.

[13]  W. Stead,et al.  Progression of renal insufficiency: role of blood pressure. , 1989, Kidney international.

[14]  J. Cutler,et al.  Renal function change in hypertensive members of the Multiple Risk Factor Intervention Trial. Racial and treatment effects. The MRFIT Research Group. , 1992 .

[15]  A. Levey,et al.  Measurement of renal function in chronic renal disease. , 1990, Kidney international.

[16]  Easterling Re.  Racial factors in the incidence and causation of end-stage renal disease (ESRD). , 1977 .

[17]  H. Dustan,et al.  Renal insufficiency in treated essential hypertension. , 1989, The New England journal of medicine.

[18]  J. Moyer,et al.  The effect of treatment on the vascular deterioration associated with hypertension, with particular emphasis on renal function. , 1958, The American journal of medicine.

[19]  M. Blaufox,et al.  Prognostic value of serum creatinine and effect of treatment of hypertension on renal function. Results from the hypertension detection and follow-up program. The Hypertension Detection and Follow-up Program Cooperative Group. , 1989, Hypertension.

[20]  D. Richardson,et al.  CHANGES IN RENAL FUNCTION ASSOCIATED WITH DRUG OR PLACEBO THERAPY OF HUMAN HYPERTENSION. , 1964, The American journal of medicine.

[21]  Can Renal Failure Due to Hypertension Be Prevented? , 1991, Hypertension.

[22]  J. Bergström,et al.  Progression of chronic renal failure in man is retarded with more frequent clinical follow-ups and better blood pressure control. , 1986, Clinical nephrology.

[23]  W. McClellan,et al.  Racial differences in the incidence of hypertensive end-stage renal disease (ESRD) are not entirely explained by differences in the prevalence of hypertension. , 1988, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[24]  W. Pettinger,et al.  Minoxidil — An Alternative to Nephrectomy for Refractory Hypertension , 1973 .

[25]  R. Lindeman,et al.  Effects of treatment in hypertension. Results of a controlled study. , 1966, Journal of chronic diseases.

[26]  W. Blythe,et al.  Hypertension as a causative diagnosis of patients entering end-stage renal disease programs in the United States from 1980 to 1986. , 1991, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[27]  N. Shock,et al.  Association between blood pressure and the rate of decline in renal function with age. , 1984, Kidney international.

[28]  A. Zuccalà,et al.  Long-term comparison between captopril and nifedipine in the progression of renal insufficiency. , 1992, Kidney international.

[29]  Effects of treatment on morbidity in hypertension. Results in patients with diastolic blood pressures averaging 115 through 129 mm Hg. , 1967, JAMA.